BridgeBio Pharma
BBIO
BBIO
250 hedge funds and large institutions have $4.43B invested in BridgeBio Pharma in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 106 increasing their positions, 73 reducing their positions, and 36 closing their positions.
Holders
250
Holders Change
+7
Holders Change %
+2.88%
% of All Funds
3.64%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.17%
New
45
Increased
106
Reduced
73
Closed
36
Calls
$306M
Puts
$85.9M
Net Calls
+$220M
Net Calls Change
+$49.2M
Top Buyers
1 |
1
BlackRock
New York
|
$315M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$54.6M |
3 |
PBA
3
Paradigm Biocapital Advisors
New York
|
$27.6M |
4 |
4
Janus Henderson Group
London,
United Kingdom
|
$109M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$356M |